Cocoon CEO Ailis Tweed-Kent to Present at Bio-Europe Spring 2016

Ailis Tweed-Kent, CEO and Founder of Cocoon Biotech, Inc., has been invited to speak at Bio-Europe Spring 2016, held April 4-6 in Stockholm, Sweden. On Monday, April 4 at 4:00 p.m. she will be a panelist on “The New Normal:  Effective Alternative Financing,” and on Tuesday, April 5 at 11:30 p.m. she will tell the Cocoon story at the company presentation session, which will provide a forum for 129 innovative startups, established biotech companies, and large and midsize pharma companies to present information on products, partnering opportunities and corporate strategy.

For more information about Bio-Europe Spring 2016, visit this page.

Peter Mitchell Named Chief Scientific Officer At Cocoon Biotech

BOSTON, Ma. — Cocoon Biotech, Inc. a biotechnology company focused on the development of osteoarthritis and other drug-delivery therapies based on its silk protein technology, has announced the appointment of Peter Mitchell, Ph.D., as Chief Scientific Officer. Dr. Mitchell brings to the position 25 years of commercial pharmaceutical leadership focused on arthritis and inflammation.

To read more from BioSpace, visit this page.